Results showed that FASN was highly expressed in CRC, and that CRC patients with higher FASN expression in tumors had shorter overall survival when classified by TNM stage (Figure 5G–I; Figure S10 and Tables S11 and S12, Supporting Information). The gene discussed is FASN; the disease is colorectal carcinoma.